Patients with nAMD often experience a gradual or sudden decrease in central vision. Common symptoms include blurred or distorted vision, difficulty reading or recognizing faces, and dark or empty areas in the center of vision. These symptoms can significantly impact daily activities, such as driving and reading.

Diagnosing nAMD involves a comprehensive eye examination. Key diagnostic tools include:

• Visual Acuity Test: Measures the clarity of vision.
• Amsler Grid Test: Detects vision changes related to the macula.
• Optical Coherence Tomography (OCT): Provides detailed images of the retina, revealing fluid or thickening.
• Fluorescein Angiography: Involves injecting a dye into the bloodstream to highlight blood vessels in the retina, identifying leaks or abnormal growth.

The primary treatment for nAMD is anti-VEGF (vascular endothelial growth factor) therapy. These medications are injected into the eye to inhibit the growth of abnormal blood vessels and reduce fluid leakage. Common anti-VEGF drugs include ranibizumab, aflibercept, and bevacizumab. Other treatments may include photodynamic therapy and laser surgery, though these are less common.

With timely and appropriate treatment, many patients with nAMD can maintain or even improve their vision. However, untreated nAMD can lead to significant and permanent vision loss. Regular monitoring and follow-up are crucial to managing the condition effectively.

The exact cause of nAMD is not fully understood, but it is believed to result from a combination of genetic, environmental, and lifestyle factors. Risk factors include age (typically affecting those over 50), smoking, family history of AMD, and cardiovascular disease.

nAMD is a major cause of vision loss in older adults worldwide. It is more prevalent in individuals of European descent and affects women slightly more than men. The incidence increases with age, particularly in those over 75 years old.

nAMD involves the growth of new, fragile blood vessels from the choroid (a layer of blood vessels beneath the retina) into the macula. These vessels can leak fluid or blood, disrupting the normal retinal structure and function, leading to vision loss. The process is driven by increased levels of VEGF, a protein that promotes blood vessel formation.

While there is no guaranteed way to prevent nAMD, certain lifestyle changes may reduce the risk. These include maintaining a healthy diet rich in leafy greens and fish, avoiding smoking, managing cardiovascular health, and protecting eyes from excessive sunlight exposure.

Neovascular Age-Related Macular Degeneration is a serious eye condition that can lead to significant vision loss if untreated. Early detection and treatment with anti-VEGF therapy are crucial for preserving vision. Understanding the risk factors and symptoms can aid in early diagnosis and management.

If you or a loved one is experiencing symptoms such as blurred or distorted vision, it is important to seek an eye examination. Regular check-ups and monitoring are essential for those at risk of nAMD. Treatment options are available that can help maintain vision and improve quality of life.